Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Change in Acquisitions & Divestments (2022 - 2025)

Strata Critical Medical (SRTA) has disclosed Change in Acquisitions & Divestments for 4 consecutive years, with $23.2 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments fell 86.93% to $23.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $226.2 million through Dec 2025, up 27.47% year-over-year, with the annual reading at $226.2 million for FY2025, 27.47% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $23.2 million at Strata Critical Medical, down from $51.7 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $238.4 million in Q4 2022, with the low at -$110.7 million in Q2 2023.
  • Average Change in Acquisitions & Divestments over 4 years is $73.6 million, with a median of $77.2 million recorded in 2024.
  • Peak annual rise in Change in Acquisitions & Divestments hit 1021.35% in 2023, while the deepest fall reached 153.02% in 2023.
  • Over 4 years, Change in Acquisitions & Divestments stood at $238.4 million in 2022, then crashed by 146.42% to -$110.7 million in 2023, then soared by 260.36% to $177.4 million in 2024, then plummeted by 86.93% to $23.2 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $23.2 million, $51.7 million, and $43.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.